Dog tail tracker, circuit printer win $10K prizes

A dog emotion tracker and a desktop circuit printer took this year's ECE Innovation Award prizes of $10,000. The competition challenges students to develop technology and demonstrate the idea’s business potential.

Inside Medicine at Weill Cornell: the dean as mentor

In the first of a series of Inside Medicine at Weill Cornell videos focusing on mentorship, explore the relationship between Dr. Sarah Bettigole and her mentor, WCMC Dean Dr. Laurie Glimcher.

Charter Day: 'The perfect capstone to an historic year'

Thousands gathered in Barton Hall Monday to mark Cornell University's 150th birthday and its impact on higher education, New York state and around the world.

Surprising factors determine successful aging

The Charter Day Weekend panel "Wellness, Fulfillment and Good Health" focused on ways to lead a healthy, fulfilling life, both physically and mentally.

Weill Cornell video series spotlights culture of mentorship

Weill Cornell Medical College is launching a video series highlighting its culture of mentorship, an essential ingredient of excellent health care, research and education.

Cornell Tech hosts computer hack day for kids, seniors

More than 30 Cornell Tech students taught coding and computer literacy to middle school students and senior citizens last week on Manhattan's Roosevelt Island.

Charles Phlegar to depart for alma mater, Virginia Tech, June 30

Charles Phlegar, vice president for alumni affairs and development since 2006, has announced he will be leaving Cornell on June 30 to become vice president for advancement at Virginia Tech.

Discovery of genetic mutations may lead to lymphoma therapy

An international team of researchers has discovered a pair of genetic mutations that drive tumor growth in patients who have a deadly subtype of T-cell lymphoma. The findings could lead to new targeted therapies for this aggressive disease.

New research amends earlier triple negative breast cancer finding

Weill Cornell Medical College investigators have invalidated a previously reported molecular finding on triple negative breast cancer that many hoped would lead to targeted treatments for the aggressive disease.